New Jersey · 2026-2027 Regular Session · Bill

A 2645: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.

In committee Last action January 13, 2026: Introduced, Referred to Assembly Health Committee

Plain-language summary

A 2645 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy. Primary sponsor: Chris DePhillips (Republican). Most recent recorded action (January 13, 2026): Introduced, Referred to Assembly Health Committee.

Sponsors

Primary sponsor: Chris DePhillips (Republican).